Chesley Taft & Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.39M | Buy |
8,669
+65
| +0.8% | +$18.4K | 0.09% | 152 |
|
|
2026
Q1 | $2.3M | Sell |
8,604
-105
| -1% | -$29.1K | 0.1% | 144 |
|
|
2025
Q4 | $2.4M | Buy |
8,709
+297
| +4% | +$83.3K | 0.09% | 143 |
|
|
2025
Q3 | $2.42M | Buy |
8,412
+6
| +0.1% | +$1.77K | 0.1% | 138 |
|
|
2025
Q2 | $2.78M | Buy |
8,406
+161
| +2% | +$51.9K | 0.12% | 124 |
|
|
2025
Q1 | $2.71M | Sell |
8,245
-120
| -1% | -$36.2K | 0.13% | 119 |
|
|
2024
Q4 | $2.31M | Sell |
8,365
-253
| -3% | -$80.6K | 0.11% | 129 |
|
|
2024
Q3 | $2.99M | Sell |
8,618
-7
| -0.1% | -$2.41K | 0.14% | 109 |
|
|
2024
Q2 | $2.85M | Sell |
8,625
-3
| -0% | -$1.03K | 0.14% | 110 |
|
|
2024
Q1 | $3.13M | Sell |
8,628
-5
| -0.1% | -$1.65K | 0.16% | 110 |
|
|
2023
Q4 | $2.59M | Buy |
8,633
+20
| +0.2% | +$5.84K | 0.15% | 118 |
|
|
2023
Q3 | $2.46M | Sell |
8,613
-7
| -0.1% | -$2K | 0.16% | 117 |
|
|
2023
Q2 | $2.42M | Sell |
8,620
-63
| -0.7% | -$16.4K | 0.15% | 124 |
|
|
2023
Q1 | $2.22M | Sell |
8,683
-328
| -4% | -$95.6K | 0.15% | 126 |
|
|
2022
Q4 | $2.99M | Sell |
9,011
-23
| -0.3% | -$7.28K | 0.21% | 112 |
|
|
2022
Q3 | $2.51M | Sell |
9,034
-15
| -0.2% | -$4.22K | 0.18% | 115 |
|
|
2022
Q2 | $2.38M | Sell |
9,049
-165
| -2% | -$42.5K | 0.16% | 119 |
|
|
2022
Q1 | $2.35M | Hold |
9,214
| – | – | 0.14% | 125 |
|
|
2021
Q4 | $2.12M | Hold |
9,214
| – | – | 0.11% | 136 |
|
|
2021
Q3 | $1.84M | Hold |
9,214
| – | – | 0.11% | 139 |
|
|
2021
Q2 | $2.18M | Sell |
9,214
-98
| -1% | -$24.5K | 0.13% | 131 |
|
|
2021
Q1 | $2.27M | Sell |
9,312
-227
| -2% | -$50.6K | 0.14% | 125 |
|
|
2020
Q4 | $1.99M | Sell |
9,539
-75
| -0.8% | -$14.7K | 0.13% | 123 |
|
|
2020
Q3 | $1.63M | Sell |
9,614
-425
| -4% | -$74.8K | 0.12% | 131 |
|
|
2020
Q2 | $1.88M | Buy |
10,039
+438
| +5% | +$83.1K | 0.14% | 115 |
|
|
2020
Q1 | $1.7M | Buy |
9,601
+590
| +7% | +$114K | 0.15% | 109 |
|
|
2019
Q4 | $1.84M | Buy |
9,011
+66
| +0.7% | +$12.1K | 0.13% | 125 |
|
|
2019
Q3 | $1.36M | Buy |
8,945
+1,997
| +29% | +$325K | 0.11% | 138 |
|
|
2019
Q2 | $1.09M | Buy |
6,948
+791
| +13% | +$124K | 0.09% | 150 |
|
|
2019
Q1 | $990K | Sell |
6,157
-4,678
| -43% | -$854K | 0.08% | 156 |
|
|
2018
Q4 | $2.06M | Buy |
+10,835
| New | +$2.26M | 0.2% | 101 |
|
Other funds holding CI
Chesley Taft & Associates's CI Position: Q2 2026 in Review
Chesley Taft & Associates increased its Cigna (CI) stake by 0.76% in Q2 2026, buying an estimated $18.4K and bringing the position to 8,669 shares worth $2.39M. The position accounts for 0.09% of the portfolio, ranked #152.
Chesley Taft & Associates first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.13M in Q1 2024. 1,700 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Chesley Taft & Associates held 8,669 shares of Cigna worth $2.39M as of Q2 2026.
- Chesley Taft & Associates bought 65 Cigna shares in Q2 2026, an estimated $18.4K.
- Cigna made up 0.09% of Chesley Taft & Associates's portfolio in Q2 2026, its #152 holding.
- Chesley Taft & Associates first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- Chesley Taft & Associates's Cigna position peaked at $3.13M in Q1 2024.
- 1,700 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.